RA Capital Management’s KALA BIO KALA Stock Holding History

RA Capital Management’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,354	Closed	-$15M	–	93
2022 Q1	$15M	Hold	4,354	–	–	0.33%	62
2021 Q4	$13.2M	Hold	4,354	–	–	0.23%	71
2021 Q3	$28.5M	Hold	4,354	–	–	0.39%	54
2021 Q2	$57.6M	Hold	4,354	–	–	0.93%	32
2021 Q1	$73.3M	Hold	4,354	–	–	1.11%	29
2020 Q4	$73.7M	Hold	4,354	–	–	1.03%	30
2020 Q3	$81.6M	Hold	4,354	–	–	1.49%	22
2020 Q2	$114M	Hold	4,354	–	–	2.23%	15
2020 Q1	$95.6M	Buy	4,354 +2,537	+140%	+$40.5M	3.02%	12
2019 Q4	$16.7M	Hold	1,817	–	–	0.51%	29
2019 Q3	$17.3M	Hold	1,817	–	–	1.03%	20
2019 Q2	$28.9M	Hold	1,817	–	–	1.55%	17
2019 Q1	$37.5M	Hold	1,817	–	–	1.62%	17
2018 Q4	$22.2M	Buy	1,817 +971	+115%	+$16.8M	1.29%	23
2018 Q3	$20.9M	Hold	846	–	–	1.12%	20
2018 Q2	$29M	Hold	846	–	–	1.88%	17
2018 Q1	$33.5M	Hold	846	–	–	2.56%	12
2017 Q4	$39.1M	Hold	846	–	–	3.27%	9
2017 Q3	$48.3M	Buy	+846	New	+$46.4M	4.36%	8

Other funds holding KALA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

RA Capital Management's KALA Position: Q2 2022 in Review

RA Capital Management sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 4,354 shares — an estimated $15M sold.

RA Capital Management first reported a position in KALA in Q3 2017 and held it in 19 quarters. The position peaked at $114M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

RA Capital Management reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
RA Capital Management sold 4,354 KALA BIO shares in Q2 2022, an estimated $15M.
RA Capital Management first reported a position in KALA BIO in Q3 2017 and held it in 19 quarters.
RA Capital Management's KALA BIO position peaked at $114M in Q2 2020.
63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on RA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.